Sarcoma, Ewing
Conditions
Keywords
sarcoma; ewing
Brief summary
Extraction of laboratory data from blood tests prior to surgical and chemotherapy and other histological, clinical and instrumental data related to the patient's history from the digitized medical Digitized medical records and analysis of the same. The medical records of 1000 patients from January 1, 2000, until December 31, 2020
Interventions
Patients with Ewing's Sarcoma and osteosarcoma with established diagnosis
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with Ewing's Sarcoma and osteosarcoma with established diagnosis; * Patients with age ≥ 2 years; * Minimum follow-up duration of 2 years; * Medical records, complete blood work and instrumental examinations; Regular follow-up.
Exclusion criteria
* Patients with Ewing's sarcoma or osteosarcoma who have received medical treatment (surgery radiotherapy or chemotherapy) in other institutions prior to admission to the Rizzoli Orthopaedic Institute.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 5-year survival | at baseline (Day0) | Evaluation of 5-year survival in relation to histologic, laboratory, clinical, and instrumental laboratory, clinical and instrumental factors |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of local recurrence | at baseline (Day0) | Evaluation of the rate of local recurrence and distant metastasis in relation to prognostic factors histological, laboratory, clinical and instrumental factors; |
Countries
Italy